Market Research Reports, Inc.

Epidemiological Forecast on Alzheimer's Disease Upto 2022

This report provides important information on epidemiological forecast for 10years i.e. upto 2022, which includes the number of cases that are prevalent in Alzheimer’s, segmented by sex and age between 60 years and 90 years.

 

Lewes, DE -- (SBWIRE) -- 03/04/2013 -- Alzheimer's disease is one of the main causes of dementia, which is a slowly progressive disease of the brain. This disease is more common in people aged between 60 years and older. The symptoms of this disease include memory loss, anxiety and loss in clarity of vision. This disease is mainly caused due to lifestyle and aging factor. In the near future, globally there will be a huge demand for care of persons those who are affected with this disease, mainly driven by the continuous increase in the number of Alzheimer's disease cases, along with the aging world population.

Inquire about this report: EpiCast Report: Alzheimer's Disease - Epidemiology Forecast to 2022

The report provides important information on epidemiological forecast for 10years, which includes the number of cases that are prevalent in Alzheimer’s, segmented by sex and age between 60 years and 90 years.

This report also provides information about the risk factors and comorbidities (any other disorder) associated with Alzheimer's disease and also provide information about the global trends in seven major markets across the world, which includes U.S, Italy, France, Germany, UK and Japan, along with emerging markets such as India and China.

Key highlights of the report

In 2009, the total number of dementia cases throughout the world was around 75% and in people of age 60 and older, the global occurrence of dementia is around 3.9%. In US, the overall population of Alzheimer's disease is 9.7%, in Europe it is 4.4% and in other developing countries it is 3.4%. The total number of cases of Alzheimer's disease in the nine major markets such as US, Germany, France, Spain, Italy, UK, Japan, India and China is expected to reach 16.72 million cases in 2022 from 12.53 million cases in 2012, with an annual growth rate (AGR) of 3.35%, according to the predictions made by a team of expert epidemiologists.

In different parts of the world, there is a rapid increase of Alzheimer's disease, mainly because of the significant growth of aging population. At present there is no cure for Alzheimer's disease, according to the data given by Mayo Clinic.

“Epidemiological forecast on Alzheimer's disease upto 2022 “is specifically useful for the reader to develop business strategies by understanding the trends shaping and driving the global Alzheimer's disease market, provides an outlook on the number of patient populations in the global Alzheimer's disease market in order to improve the product development, pricing, and launch plans. It also helps to organize sales and marketing, by identifying gender and age groups, which will in-turn help in providing best opportunities for Alzheimer's therapeutics in each of the markets covered.

Inquire about this report: EpiCast Report: Alzheimer's Disease - Epidemiology Forecast to 2022